Melatonin, the compound that is found in the body and has been shown to help regulate sleep rhythms as well as increase some people’s resistance to conditions such as seasonal affective disorder (SAD), may be a boon for women going through IVF treatments. 

In fact, a presentation of a study at the World Congress of Fertility and Sterility strongly proved that females who were given doses of melatonin during IVF treatments were shown to double their chances at pregnancy.

The scientists who initiated the study feel that because melatonin is an oxidizer, it may help to mitigate damage to eggs that have been harmed.  During their IVF treatmentstudy at Yamaguchi University Graduate School of Medicine, researchers discovered that women who were given melatonin more than doubled their chances of having an egg fertilized through the IVF process.

More research will be done, of course, but the findings could open the doors for stronger success rates among females undergoing IVF treatments.